2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide

C131H251F6N23O12 — CID 167675056

IUPAC2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide
SMILESCC(C)C(C)C(=O)NC1CCN(C(C)C)CC1O.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1CCN(C(C)C)CC1O.CC(C)N1CCC(NC(=O)C2(C(F)(F)F)CC2)C(O)C1.CC(C)N1CCC(NC(=O)C2(C(F)(F)F)CCC2)C(O)C1.CCN1CCN(CC2(NC(=O)C(C)C(C)C)CCN(C(C)C)CC2)CC1.CCN1CCN(CC2(NC(=O)CC(C)C)CCN(C(C)C)CC2)CC1.CCN1CCN(CC2(NC(=O)CC3CC3)CCN(C(C)C)CC2)CC1
InChIInChI=1S/C21H42N4O.C20H38N4O.C20H40N4O.C16H33N3O.C14H23F3N2O2.C14H28N2O2.C13H21F3N2O2.C13H26N2O2/c1-7-23-12-14-24(15-13-23)16-21(22-20(26)19(6)17(2)3)8-10-25(11-9-21)18(4)5;1-4-22-11-13-23(14-12-22)16-20(21-19(25)15-18-5-6-18)7-9-24(10-8-20)17(2)3;1-6-22-11-13-23(14-12-22)16-20(21-19(25)15-17(2)3)7-9-24(10-8-20)18(4)5;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-9(2)19-7-4-10(11(20)8-19)18-12(21)13(5-3-6-13)14(15,16)17;1-9(2)11(5)14(18)15-12-6-7-16(10(3)4)8-13(12)17;1-8(2)18-6-3-9(10(19)7-18)17-11(20)12(4-5-12)13(14,15)16;1-9(2)7-13(17)14-11-5-6-15(10(3)4)8-12(11)16/h17-19H,7-16H2,1-6H3,(H,22,26);17-18H,4-16H2,1-3H3,(H,21,25);17-18H,6-16H2,1-5H3,(H,21,25);13-14H,7-12H2,1-6H3,(H,17,20);9-11,20H,3-8H2,1-2H3,(H,18,21);9-13,17H,6-8H2,1-5H3,(H,15,18);8-10,19H,3-7H2,1-2H3,(H,17,20);9-12,16H,5-8H2,1-4H3,(H,14,17)
InChIKeyURLSWMHAYRHLFS-UHFFFAOYSA-N
MW2454.59 g/mol
LogP13.24
Rot. Bonds41

About 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide

2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide (PubChem CID 167675056) has the molecular formula C131H251F6N23O12 and a molecular weight of 2454.59 g/mol. Its IUPAC name is 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide.

Molecular Properties

Compound Name2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide
PubChem CID167675056
Molecular FormulaC131H251F6N23O12
Molecular Weight2454.59 g/mol
Exact Mass2452.96
IUPAC Name2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide
SMILESCC(C)C(C)C(=O)NC1CCN(C(C)C)CC1O.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1CCN(C(C)C)CC1O.CC(C)N1CCC(NC(=O)C2(C(F)(F)F)CC2)C(O)C1.CC(C)N1CCC(NC(=O)C2(C(F)(F)F)CCC2)C(O)C1.CCN1CCN(CC2(NC(=O)C(C)C(C)C)CCN(C(C)C)CC2)CC1.CCN1CCN(CC2(NC(=O)CC(C)C)CCN(C(C)C)CC2)CC1.CCN1CCN(CC2(NC(=O)CC3CC3)CCN(C(C)C)CC2)CC1
InChIInChI=1S/C21H42N4O.C20H38N4O.C20H40N4O.C16H33N3O.C14H23F3N2O2.C14H28N2O2.C13H21F3N2O2.C13H26N2O2/c1-7-23-12-14-24(15-13-23)16-21(22-20(26)19(6)17(2)3)8-10-25(11-9-21)18(4)5;1-4-22-11-13-23(14-12-22)16-20(21-19(25)15-18-5-6-18)7-9-24(10-8-20)17(2)3;1-6-22-11-13-23(14-12-22)16-20(21-19(25)15-17(2)3)7-9-24(10-8-20)18(4)5;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-9(2)19-7-4-10(11(20)8-19)18-12(21)13(5-3-6-13)14(15,16)17;1-9(2)11(5)14(18)15-12-6-7-16(10(3)4)8-13(12)17;1-8(2)18-6-3-9(10(19)7-18)17-11(20)12(4-5-12)13(14,15)16;1-9(2)7-13(17)14-11-5-6-15(10(3)4)8-12(11)16/h17-19H,7-16H2,1-6H3,(H,22,26);17-18H,4-16H2,1-3H3,(H,21,25);17-18H,6-16H2,1-5H3,(H,21,25);13-14H,7-12H2,1-6H3,(H,17,20);9-11,20H,3-8H2,1-2H3,(H,18,21);9-13,17H,6-8H2,1-5H3,(H,15,18);8-10,19H,3-7H2,1-2H3,(H,17,20);9-12,16H,5-8H2,1-4H3,(H,14,17)
InChIKeyURLSWMHAYRHLFS-UHFFFAOYSA-N
XLogP13.24
TPSA362.32 Ų
H-Bond Donors12
H-Bond Acceptors27
Rotatable Bonds41
Heavy Atoms172
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002454.59
LogP ≤ 513.24
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1027

Analyze 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;propan-2-yl N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]carbamate;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide
CID 157722953
N-(5,5-difluoropiperidin-3-yl)-2-methylpropanamide;N-(1,3-dimethylpiperidin-3-yl)-2-methylpropanamide;N-(1,4-dimethylpiperidin-4-yl)-2-methylpropanamide;N,2-dimethyl-N-piperidin-4-ylpropanamide;N-[(3R,4S)-3-fluoropiperidin-4-yl]-2-methylpropanamide;N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-methylpropanamide;N-[(3R,4R)-3-fluoropiperidin-4-yl]-2-methylpropanamide;N-[(3S,4S)-4-fluoropiperidin-3-yl]-2-methylpropanamide;N-[(3R,4R)-4-fluoropiperidin-3-yl]-2-methylpropanamide;N-(4-fluoropiperidin-3-yl)-2-methylpropanamide;N-(3-hydroxy-1-methylpiperidin-4-yl)-2-methylpropanamide;N-(4-hydroxy-1-methylpiperidin-3-yl)-2-methylpropanamide
CID 157766562
N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-hydroxy-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclopropane-1-carboxamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide
CID 158217093
N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-(dimethylamino)-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclopentane-1-carboxamide;1-hydroxy-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclopropane-1-carboxamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide
CID 159040820
N-(4-amino-1-propan-2-ylpyrrolidin-3-yl)-3-methylbutanamide;tert-butyl N-[3-[2-(dimethylamino)ethoxy]-1-propan-2-ylpiperidin-4-yl]carbamate;2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-methylcyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide;propan-2-yl N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)carbamate
CID 159732931
N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide
CID 160175777
N-(4-amino-1-propan-2-ylpyrrolidin-3-yl)-3-methylbutanamide;tert-butyl N-[3-[2-(dimethylamino)ethoxy]-1-propan-2-ylpiperidin-4-yl]carbamate;2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-methylcyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide;propan-2-yl N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)carbamate
CID 160365827
2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-2-(1-methoxycyclopropyl)acetamide;2,3-dimethyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide
CID 161005109
N-(4-amino-1-propan-2-ylpyrrolidin-3-yl)-3-methylbutanamide;tert-butyl N-[3-[2-(dimethylamino)ethoxy]-1-propan-2-ylpiperidin-4-yl]carbamate;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-methylcyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide;propan-2-yl N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)carbamate
CID 162150081
N-(4-amino-1-propan-2-ylpyrrolidin-3-yl)-3-methylbutanamide;2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-methylcyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide;propan-2-yl N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)carbamate
CID 162166184
2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide
CID 162205605
N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide
CID 167585094

Frequently Asked Questions

What is the IUPAC name of 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide?
The IUPAC name of 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide (CID 167675056) is 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide.
What is the SMILES notation for 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide?
The canonical SMILES for 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide is CC(C)C(C)C(=O)NC1CCN(C(C)C)CC1O.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1CCN(C(C)C)CC1O.CC(C)N1CCC(NC(=O)C2(C(F)(F)F)CC2)C(O)C1.CC(C)N1CCC(NC(=O)C2(C(F)(F)F)CCC2)C(O)C1.CCN1CCN(CC2(NC(=O)C(C)C(C)C)CCN(C(C)C)CC2)CC1.CCN1CCN(CC2(NC(=O)CC(C)C)CCN(C(C)C)CC2)CC1.CCN1CCN(CC2(NC(=O)CC3CC3)CCN(C(C)C)CC2)CC1.
What is the InChIKey of 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide?
The InChIKey is URLSWMHAYRHLFS-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H42N4O.C20H38N4O.C20H40N4O.C16H33N3O.C14H23F3N2O2.C14H28N2O2.C13H21F3N2O2.C13H26N2O2/c1-7-23-12-14-24(15-13-23)16-21(22-20(26)19(6)17(2)3)8-10-25(11-9-21)18(4)5;1-4-22-11-13-23(14-12-22)16-20(21-19(25)15-18-5-6-18)7-9-24(10-8-20)17(2)3;1-6-22-11-13-23(14-12-22)16-20(21-19(25)15-17(2)3)7-9-24(10-8-20)18(4)5;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-9(2)19-7-4-10(11(20)8-19)18-12(21)13(5-3-6-13)14(15,16)17;1-9(2)11(5)14(18)15-12-6-7-16(10(3)4)8-13(12)17;1-8(2)18-6-3-9(10(19)7-18)17-11(20)12(4-5-12)13(14,15)16;1-9(2)7-13(17)14-11-5-6-15(10(3)4)8-12(11)16/h17-19H,7-16H2,1-6H3,(H,22,26);17-18H,4-16H2,1-3H3,(H,21,25);17-18H,6-16H2,1-5H3,(H,21,25);13-14H,7-12H2,1-6H3,(H,17,20);9-11,20H,3-8H2,1-2H3,(H,18,21);9-13,17H,6-8H2,1-5H3,(H,15,18);8-10,19H,3-7H2,1-2H3,(H,17,20);9-12,16H,5-8H2,1-4H3,(H,14,17).
What are the key properties of 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide?
2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide has a molecular weight of 2454.59 g/mol, XLogP of 13.24, 41 rotatable bonds, 12 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopropyl-N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-2,3-dimethylbutanamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-2,3-dimethylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclobutane-1-carboxamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-1-(trifluoromethyl)cyclopropane-1-carboxamide is sourced from PubChem (CID 167675056), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).